BG
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Secondary prevention therapies following percutaneous coronary intervention or acute coronary syndrome in patients with diabetes mellitus | Frontiers in cardiovascular medicine |  | 2024 | 35 | 2 | ||
| Routine beta-blocker therapy after acute coronary syndromes : The end of an era ? | European journal of clinical investigation | | 2024 | 18 | 12 | ||
| Higher 1-year mortality on rest days in patients with acute coronary syndromes and decompensated heart failure-A SPUM-ACS sub-study | Catheterization and cardiovascular interventions |  | 2024 | 3 | 0 | ||
| Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromes | Atherosclerosis plus | | 2024 | 1 | 0 | ||
| Drinking patterns of alcohol and risk of major adverse cardiovascular events after an acute coronary syndrome | European journal of preventive cardiology | | 2024 | 59 | 65 | ||
| Mid-term changes in cognitive functions in patients with atrial fibrillation : a longitudinal analysis of the Swiss-AF cohort | Frontiers in cardiovascular medicine | | 2023 | 56 | 39 | ||
| Smoking cessation in people with and without diabetes after acute coronary syndrome | Nicotine & tobacco research | | 2023 | 72 | 13 | ||
| Improving atrial fibrillation outcomes through interclinician electronic consultation | European journal of clinical investigation | | 2023 | 3 | 4 | ||
| Initial systolic blood pressure associates with systemic inflammation, myocardial injury, and outcomes in patients with acute coronary syndromes | European heart journal. Acute cardiovascular care | | 2023 | 56 | 117 | ||
| Management of dyslipidemia in patientswith cardiovascular disease” | | 2023 | 102 | 20 | |||
| « Heart Team » : le cœur de la cardiologie | Revue médicale suisse | | 2023 | 1 | 0 | ||
| Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation : A prospective cohort study | International journal of stroke | | 2023 | 66 | 57 | ||
| Risk Factors for the Development of New-Onset Persistent Atrial Fibrillation : Subanalysis of the VITAL Study | Circulation. Arrhythmia and electrophysiology | | 2023 | 70 | 69 | ||
| In-hospital initiation of PCSK9 inhibitors in ACS : pros and cons | EuroIntervention | | 2023 | 94 | 87 | ||
| Lipid-lowering trials are not representative of patients managed in clinical practice : a systematic review and meta-analysis of exclusion criteria | Journal of the American Heart Association. Cardiovascular and cerebrovascular disease | | 2023 | 113 | 156 | ||
| Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups | The American heart journal | | 2022 | 485 | 133 | ||
| Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism | Frontiers in endocrinology | | 2022 | 233 | 110 | ||
| Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex | Circulation | | 2022 | 230 | 27 | ||
| Polypharmacie et medicaments inappropriés chez les patients âgés multimorbides - Ce que l’étude OPERAM nous apprend et va nous apprendre | Revue médicale suisse | | 2022 | 196 | 0 | ||
| Long-term effects of systematic smoking cessation counselling during acute coronary syndrome, a multicentre before-after study | Swiss medical weekly | | 2022 | 71 | 33 | ||
| Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndrome | European journal of preventive cardiology | | 2022 | 100 | 0 | ||
| Study design and rationale for the Olpasiran trials of Cardiovascular Events And lipoproteiN(a) reduction-DOSE finding study (OCEAN(a)-DOSE) | American heart journal | | 2022 | 101 | 134 | ||
| European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology | European journal of preventive cardiology | | 2022 | 256 | 0 | ||
| Oméga-3 fortement dosés pour la prévention cardiovasculaire : une fausse bonne idée ? | Revue médicale suisse | | 2022 | 299 | 1 | ||
| 2021 European guidelines on cardiovascular prevention: Challenges for an evidence-based patient care | European journal of clinical investigation | | 2022 | 207 | 1 | ||
| European Society of Cardiology quality indicators for the cardiovascular pre-operative assessment and management of patients considered for non-cardiac surgery. Developed in collaboration with the European Society of Anaesthesiology and Intensive Care | European heart journal. Quality of care & clinical outcomes | | 2022 | 68 | 208 | ||
| Renal dysfunction and outcome in left ventricular non-compaction | Cardiology Journal | | 2022 | 83 | 106 | ||
| Inclisiran in primary prevention : reality or fiction ? | European heart journal | | 2022 | 127 | 0 | ||
| Impact of malignancy on clinical outcomes in patients with acute coronary syndromes | International journal of cardiology | | 2021 | 184 | 0 | ||
| Association between self-reported motivation to quit smoking with effectiveness of smoking cessation intervention among patients hospitalized for acute coronary syndromes in Switzerland | Preventive medicine reports | | 2021 | 200 | 107 | ||
| Prognostic value of total testosterone levels in patients with acute coronary syndromes | European Journal of Preventive Cardiology | | 2021 | 483 | 3 | ||
| Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events | Atherosclerosis | | 2021 | 221 | 35 | ||
| Prognostic value of inflammatory biomarkers and GRACE score for cardiac death and acute kidney injury after acute coronary syndromes | European heart journal. Acute cardiovascular care | | 2021 | 188 | 199 | ||
| Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes | Journal of the American Heart Association | | 2021 | 206 | 103 | ||
| Cardiovascular risk and testosterone - from subclinical atherosclerosis to lipoprotein function to heart failure | Reviews in endocrine and metabolic disorders | | 2021 | 210 | 136 | ||
| CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patients | Atherosclerosis | | 2021 | 163 | 44 | ||
| Air pollution triggers inflammation and cardiovascular events: now is the time to act | European heart journal | | 2021 | 159 | 0 | ||
| Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelines | European journal of preventive cardiology | | 2021 | 162 | 0 | ||
| Improving 1-year mortality prediction in ACS patients using machine learning | European heart journal. Acute cardiovascular care | | 2021 | 172 | 1 | ||
| Dynamical analysis in a self-regulated system undergoing multiple excitations: first order differential equation approach | Multivariate Behavioral Research | | 2021 | 234 | 209 | ||
| Antibodies against apolipoprotein a-1 as disruptors of cellular cholesterol homeostasis promoting foam cell formation | 88th EAS (European Atherosclerosis Society) Congress | 2020 | 58 | 0 | |||
| Optimal timing of invasive coronary angiography following NSTEMI | Journal of interventional cardiology | | 2020 | 234 | 109 | ||
| Emerging Concepts and Applied Machine Learning Research in Patients with Drug-Induced Repolarization Disorders | Studies in Health Technology and Informatics | | 2020 | 497 | 178 | ||
| Efficacy of evolocumab on cardiovascular outcomes in patients with recent myocardial infarction: a prespecified secondary analysis from the FOURIER trial | JAMA cardiology | | 2020 | 280 | 295 | ||
| Cognition After Lowering LDL-Cholesterol With Evolocumab | Journal of the American College of Cardiology | | 2020 | 154 | 0 | ||
| Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort study | European heart journal. Acute cardiovascular care | | 2020 | 178 | 0 | ||
| The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism | Circulation | | 2020 | 234 | 124 | ||
| Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohort | International journal of cardiology | | 2020 | 219 | 0 | ||
| Prognosis of patients with Chronic and Hospital-Acquired Anaemia After Acute Coronary Syndromes | Journal of cardiovascular translational research | | 2020 | 169 | 94 | ||
| Control of cardiovascular risk factors and health behaviors in patients post acute coronary syndromes eligible for protein convertase subtilisin/kexin-9 inhibitors | International journal of cardiology | | 2020 | 157 | 0 | ||
| Potential of lipoprotein(a)-lowering strategies in treating coronary artery disease | Drugs | | 2020 | 180 | 0 | ||
| C-terminus apoa-1 mimetic peptides to detect cognate auto-antibodies and reverse HIV-induced foam cell formation | Atherosclerosis | | 2020 | 247 | 0 | ||
| The Impact of Levothyroxine on Cardiac Function in Older Adults With Mild Subclinical Hypothyroidism: A Randomized Clinical Trial | The American journal of medicine | | 2020 | 226 | 129 | ||
| Right ventricle and outcome in left ventricular non-compaction cardiomyopathy | Journal of cardiology | | 2020 | 167 | 96 | ||
| Gender and age differences in outcomes of patients with acute coronary syndromes referred for coronary angiography | Catheterization and Cardiovascular Interventions | | 2019 | 317 | 0 | ||
| Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohort | Atherosclerosis | | 2019 | 432 | 1 | ||
| Non-linear relationship between anti-apolipoprotein A-1 IgGs and cardiovascular outcomes in patients with acute coronary syndromes | Journal of Clinical Medicine | | 2019 | 430 | 172 | ||
| Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes | European Journal of Clinical Investigation | | 2019 | 395 | 2 | ||
| Anti-ApoA-1 IgGs in Familial Hypercholesterolemia Display Paradoxical Associations with Lipid Profile and Promote Foam Cell Formation | Journal of clinical medicine | | 2019 | 238 | 143 | ||
| Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention | PloS one | | 2019 | 54 | 51 | ||
| Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized Trial | The journal of clinical endocrinology and metabolism | | 2018 | 463 | 94 | ||
| Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients | Journal of Infection | | 2018 | 575 | 1 | ||
| Impact of long distance rowing on biological health: A pilot study | Clinical Biochemistry | | 2018 | 561 | 0 | ||
| Etat des connaissances en 2018 sur les anticorps anti-PCSK9 | Revue médicale suisse | | 2018 | 229 | 88 | ||
| Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update | European heart journal | | 2018 | 234 | 120 | ||
| Inhibiteurs de PCSK9 | Forum médical suisse | | 2017 | 201 | 53 | ||
| Multi-organ injuries due to a lightning strike: a case report highlighting the importance of a multi-disciplinary approach | Case reports in plastic surgery & hand surgery | | 2017 | 550 | 248 | ||
| The fear of dying and occurrence of posttraumatic stress symptoms after an acute coronary syndrome: A prospective observational study | Journal of health psychology | | 2017 | 551 | 597 | ||
| The peak of blood lactate during the first 24h predicts mortality in acute coronary syndrome patients under extracorporeal membrane oxygenation | International journal of cardiology | | 2016 | 635 | 0 | ||
| A Randomized Study of SheathLess vs Standard Guiding Catheters for Transradial Percutaneous Coronary Interventions | Canadian journal of cardiology | 2016 | 549 | 0 | |||
| Prognostic value of PCSK9 levels in patients with acute coronary syndromes | European heart journal | | 2016 | 625 | 2 | ||
| Health utility indexes in patients with acute coronary syndromes | Open heart | | 2016 | 555 | 258 | ||
| Early Discharge in Low-Risk Patients Hospitalized for Acute Coronary Syndromes: Feasibility, Safety and Reasons for Prolonged Length of Stay | PloS one | | 2016 | 852 | 364 | ||
| Pre-hospital alarm activation for STEMI patients undergoing primary percutaneous coronary intervention in the era of transradial procedures | European Journal of Internal Medicine | | 2016 | 504 | 1 | ||
| Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population | European journal of clinical investigation | | 2015 | 656 | 0 | ||
| Use and role of monoclonal antibodies and other biologics in preventive cardiology | Schweizerische medizinische Wochenschrift | | 2015 | 656 | 305 | ||
| Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness Analysis | PloS one | | 2015 | 520 | 290 | ||
| Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes | Atherosclerosis | | 2015 | 783 | 536 | ||
| La testostérone : un traitement pour la prévention des maladies cardiovasculaires ? | Revue médicale suisse | | 2014 | 496 | 0 | ||
| Subclinical Thyroid Dysfunction and Cardiovascular Outcomes among Prospective Cohort Studies | Endocrine, metabolic & immune disorders. Drug targets. | | 2013 | 178 | 165 | ||
| Subclinical Hyperthyroidism and the Risk of Coronary Heart Disease and Mortality | Archives of internal medicine | | 2012 | 168 | 36 | ||
| Subclinical Thyroid Dysfunction and the Risk of Heart Failure Events: an individual participant data analysis from 6 prospective cohorts | Circulation | | 2012 | 200 | 95 | ||
| Quels niveaux de cholestérol devrait-on traiter en Suisse? | Forum médical suisse | | 2011 | 182 | 65 |
